Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Ronald, Vender"'
Autor:
Melinda Gooderham, Ronald Vender, Jeffrey Crowley, H. Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, Lawrence Green
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 2, Pp 441-451 (2024)
Abstract Introduction When assessing the effect of a therapy for psoriasis (PsO), it is important to consider speed of response and cumulative response. However, responses among biologics may differ by body regions. This post hoc analysis compares sp
Externí odkaz:
https://doaj.org/article/f00c3bb6c4ff40e9a728bb090f968f07
Autor:
Katrina D. Cirone, HBSc, Mohamed Akrout, BSCEN, MScAC, Daiana R. Pur, BMSc, MESc, Ronald Vender, MD, FRCPC
Publikováno v:
JAAD International, Vol 13, Iss , Pp 181-183 (2023)
Externí odkaz:
https://doaj.org/article/1f23aa59314d47ba812fbede1952ff4d
Autor:
Ahmed Bagit, BSc, Khalad Maliyar, MD, Jorge R. Georgakopoulos, MD, Brian Rankin, BSc, Alexander Rimke, MSc, Asfandyar Mufti, MD, Heather Le, CRC, Ronald Vender, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD
Publikováno v:
JAAD International, Vol 12, Iss , Pp 136-138 (2023)
Externí odkaz:
https://doaj.org/article/d0a9d1562b564b86a73ba0fd0b23453a
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 111 (2024)
The introduction of biologic agents for the treatment of psoriasis has revolutionized the current treatment landscape, targeting cytokines in the interleukin (IL)-23/IL-17 pathway and demonstrating strong efficacy and safety profiles in clinical tria
Externí odkaz:
https://doaj.org/article/9044b97874224b68a205aef095b33c69
Autor:
Fiona M Landells, Ronald Vender
Publikováno v:
SAGE Open Medical Case Reports, Vol 11 (2023)
Adalimumab is a tumor necrosis factor inhibitor that has been widely used since the early 2000s for the treatment of psoriasis and psoriatic arthritis. All tumor necrosis factor inhibitors have been identified as causative agents in drug induced lupu
Externí odkaz:
https://doaj.org/article/c01aed3eeaf447488b488de234d776ba
Autor:
Ronald Vender, MD, Irina Turchin, MD, Perla Lansang, MD, Vimal H. Prajapati, MD, Mark Legault, PhD, Maxime Barakat, MD, PhD, MBA, Jensen Yeung, MD
Publikováno v:
JAAD International, Vol 8, Iss , Pp 60-63 (2022)
Externí odkaz:
https://doaj.org/article/a53ddb810c5f4625922358a67799b58b
Publikováno v:
Journal of International Medical Research, Vol 51 (2023)
Over the past two decades, promising advancements have emerged in the field of psoriasis management. Most notably, highly effective targeted biologic therapies that offered significant breakthroughs in the management of psoriasis have been developed.
Externí odkaz:
https://doaj.org/article/4a173c97b8674e09acd32a496d78543c
Autor:
Katrina Cirone, Ronald Vender
Publikováno v:
SAGE Open Medical Case Reports, Vol 11 (2023)
A large number of autoimmune and fibrosing conditions associated with psoriasis and morphea have been reported in the literature. Currently, the relationship between psoriasis and morphea is unknown, and the coexistence of these conditions is quite r
Externí odkaz:
https://doaj.org/article/c7654b5c0b394e478bcdcb657dc73155
Autor:
Brian D. Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva, Asfandyar Mufti, Alim R. Devani, Melinda J. Gooderham, Chih-Ho Hong, Vipul Jain, Perla Lansang, Ronald Vender, Jensen Yeung, Vimal H. Prajapati
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 5, Pp 2692-2694 (2022)
Externí odkaz:
https://doaj.org/article/431f169fe789452bb44c5ddb65a34c49
Autor:
Alexander Egeberg, Lars Erik Kristensen, Ronald Vender, Shirin Zaheri, Celine El Baou, Gaia Gallo, Elisabeth Riedl, Christopher Schuster
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Nail psoriasis is a chronic, difficult-to-treat condition affecting almost half of patients with psoriasis. It is associated with considerable social stigma and impairment of patients’ quality of life. The aim of this study was to assess improvemen
Externí odkaz:
https://doaj.org/article/503549c24a21457fa10bb1ea616673a4